ArticleAnnals of translational medicine2020

The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question-are polyphenols a viable therapeutic option against proteinopathies?

Gal BitanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.